+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Women's Health Diagnostics Market Research Report by Application, by End User, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5124643
  • Report
  • September 2021
  • Region: United States
  • 81 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Women’s Health Diagnostics Market Will Grow to USD 11,942.37 Million by 2026, at a CAGR of 7.53%
The United States Women’s Health Diagnostics Market size was estimated at USD 7,721.50 Million in 2020 and expected to reach USD 8,179.18 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.53% to reach USD 11,942.37 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Women’s Health Diagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Women’s Health Diagnostics Market was studied across Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Ovarian Cancer Testing, Pregnancy and Fertility Testing, Prenatal Genetic Screening and Carrier Testing, Sexually Transmitted Disease Testing, and Ultrasound Tests. The Breast Cancer Testing is further studied across Biopsies, Blood Chemistries and Blood Cell Count Tests, Breast Cancer Tumor Marker Tests, and Mammography. The Cervical Cancer Testing is further studied across HPV Testing and PAP Smear. The Infectious Disease Testing is further studied across HEPAtitis Testing, MRSA Testing, Tuberculosis Testing, and Urinary Tract Infection Testing (Vaginal Ph & Vaginitis). The Osteoporosis Testing is further studied across Bone Densitometry and in Vitro Blood Tests. The Ovarian Cancer Testing is further studied across Diagnostic Imaging Tests and Ovarian Cancer Tumor Marker Tests. The Pregnancy and Fertility Testing is further studied across Fertility Monitors, Lab-Based Testing, and Pregnancy Testing and Ovulation Prediction Kits. The Prenatal Genetic Screening and Carrier Testing is further studied across Cystic Fibrosis, Down Syndrome and Edwards Syndrome, and Torch Infections. The Sexually Transmitted Disease Testing is further studied across Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing and HIV Testing. The Ultrasound Tests is further studied across Breast Imaging and OB/GYN Imaging.
  • Based on Type, the Women’s Health Diagnostics Market was studied across Point-of-care and Self Check.
  • Based on End User, the Women’s Health Diagnostics Market was studied across Diagnostic and Imaging Centers, Home Care, and Hospitals and Clinics.
  • Based on State, the Women’s Health Diagnostics Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Women’s Health Diagnostics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Women’s Health Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Women’s Health Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Women’s Health Diagnostics Market?
4. What is the competitive strategic window for opportunities in the United States Women’s Health Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the United States Women’s Health Diagnostics Market?
6. What is the market share of the leading vendors in the United States Women’s Health Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the United States Women’s Health Diagnostics Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. State Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Women’s Health Diagnostics Market, by Application
6.1. Introduction
6.2. Breast Cancer Testing
6.2.1. Biopsies
6.2.2. Blood Chemistries and Blood Cell Count Tests
6.2.3. Breast Cancer Tumor Marker Tests
6.2.4. Mammography
6.3. Cervical Cancer Testing
6.3.1. HPV Testing
6.3.2. PAP Smear
6.4. Infectious Disease Testing
6.4.1. HEPAtitis Testing
6.4.2. MRSA Testing
6.4.3. Tuberculosis Testing
6.4.4. Urinary Tract Infection Testing (Vaginal Ph & Vaginitis)
6.5. Osteoporosis Testing
6.5.1. Bone Densitometry
6.5.2. in Vitro Blood Tests
6.6. Ovarian Cancer Testing
6.6.1. Diagnostic Imaging Tests
6.6.2. Ovarian Cancer Tumor Marker Tests
6.7. Pregnancy and Fertility Testing
6.7.1. Fertility Monitors
6.7.2. Lab-Based Testing
6.7.3. Pregnancy Testing and Ovulation Prediction Kits
6.8. Prenatal Genetic Screening and Carrier Testing
6.8.1. Cystic Fibrosis
6.8.2. Down Syndrome and Edwards Syndrome
6.8.3. Torch Infections
6.9. Sexually Transmitted Disease Testing
6.9.1. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing
6.9.2. HIV Testing
6.10. Ultrasound Tests
6.10.1. Breast Imaging
6.10.2. OB/GYN Imaging

7. Women’s Health Diagnostics Market, by Type
7.1. Introduction
7.2. Point-of-care
7.3. Self Check

8. Women’s Health Diagnostics Market, by End User
8.1. Introduction
8.2. Diagnostic and Imaging Centers
8.3. Home Care
8.4. Hospitals and Clinics

9. California Women’s Health Diagnostics Market
9.1. Introduction

10. Florida Women’s Health Diagnostics Market
10.1. Introduction

11. Illinois Women’s Health Diagnostics Market
11.1. Introduction

12. New York Women’s Health Diagnostics Market
12.1. Introduction

13. Ohio Women’s Health Diagnostics Market
13.1. Introduction

14. Pennsylvania Women’s Health Diagnostics Market
14.1. Introduction

15. Texas Women’s Health Diagnostics Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 3. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 5. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 6. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: MARKET DYNAMICS
FIGURE 8. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 9. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2026
FIGURE 11. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 45. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, 2018-2026 (USD MILLION)
FIGURE 46. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 47. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, 2018-2026 (USD MILLION)
FIGURE 48. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 49. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, 2018-2026 (USD MILLION)
FIGURE 50. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 51. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, 2018-2026 (USD MILLION)
FIGURE 52. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 53. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, 2018-2026 (USD MILLION)
FIGURE 54. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 55. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, 2018-2026 (USD MILLION)
FIGURE 56. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 57. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, 2018-2026 (USD MILLION)
FIGURE 58. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 59. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, 2018-2026 (USD MILLION)
FIGURE 60. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 61. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, 2018-2026 (USD MILLION)
FIGURE 62. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 63. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, 2018-2026 (USD MILLION)
FIGURE 64. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 65. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2026 (USD MILLION)
FIGURE 66. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 67. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, 2018-2026 (USD MILLION)
FIGURE 68. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 69. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, 2018-2026 (USD MILLION)
FIGURE 70. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 71. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2026 (USD MILLION)
FIGURE 72. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 73. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, 2018-2026 (USD MILLION)
FIGURE 74. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 75. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, 2018-2026 (USD MILLION)
FIGURE 76. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 77. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 78. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 79. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2026
FIGURE 80. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, 2018-2026 (USD MILLION)
FIGURE 81. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 82. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, 2018-2026 (USD MILLION)
FIGURE 83. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 84. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 85. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 86. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2026
FIGURE 87. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, 2018-2026 (USD MILLION)
FIGURE 88. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 89. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2018-2026 (USD MILLION)
FIGURE 90. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 91. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2026 (USD MILLION)
FIGURE 92. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 93. CALIFORNIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 94. FLORIDA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 95. ILLINOIS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 96. NEW YORK WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 97. OHIO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 98. PENNSYLVANIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 99. TEXAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 100. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 101. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY AND FERTILITY TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING AND OVULATION PREDICTION KITS, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING AND CARRIER TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME AND EDWARDS SYNDROME, BY STATE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 34. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 35. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 36. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY STATE, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY STATE, 2018-2026 (USD MILLION)
TABLE 38. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 39. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY STATE, 2018-2026 (USD MILLION)
TABLE 40. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY STATE, 2018-2026 (USD MILLION)
TABLE 41. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC AND IMAGING CENTERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY STATE, 2018-2026 (USD MILLION)
TABLE 44. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 45. CALIFORNIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. FLORIDA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. ILLINOIS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. NEW YORK WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. OHIO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. PENNSYLVANIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. TEXAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: SCORES
TABLE 53. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: BUSINESS STRATEGY
TABLE 54. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: PRODUCT SATISFACTION
TABLE 55. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: RANKING
TABLE 56. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 57. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: MERGER & ACQUISITION
TABLE 58. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: INVESTMENT & FUNDING
TABLE 61. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 62. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll